Dietary supplements containing undisclosed pharmaceutical drugs — including steroids, thyroid hormones, and amphetamine-like stimulants — have been sold to consumers for years with limited regulatory consequence due to insufficient FDA enforcement capacity.

Verified by Lenz · Mar 25, 2026

The Short Version

The claim is substantially accurate. Peer-reviewed research documents over 1,000 dietary supplements adulterated with undisclosed pharmaceuticals — including synthetic steroids and stimulants — sold from 2007 through 2021, with some products remaining on shelves years after FDA warnings. However, the specific inclusion of "thyroid hormones" as a central adulterant pattern is not well-supported by the evidence. Additionally, the enforcement gap stems primarily from DSHEA's statutory design (classifying supplements as foods), not purely from insufficient FDA capacity — a meaningful distinction the claim obscures.

Caveats

The claim lists 'thyroid hormones' as a documented adulterant category, but the evidence primarily identifies sildenafil, sibutramine, and synthetic steroids — thyroid hormones are not prominently documented as a sustained pattern.
The enforcement shortfall is largely a statutory design problem under DSHEA (which limits pre-market authority), not solely an 'insufficient enforcement capacity' issue — these are distinct causes with different policy implications.
The FDA has taken enforcement actions including seizures, injunctions, and over 1,000 warning letters; the claim's framing of 'limited regulatory consequence' omits these actions, even though their effectiveness has been questioned.

The Receipts

Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings - PMC
PMCOct 12, 2018
Continued Risk of Dietary Supplements Adulterated With Approved and Unapproved Drugs: Assessment of the US Food and Drug Administration's Tainted Supplements Database 2007 Through 2021 - PubMed
PubMedAug 15, 2022
Research: Stimulants remain in supplements years after FDA warning letters
Journal of the American Medical AssociationJul 26, 2022
Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings - PubMed
PubMedOct 5, 2018
Too Little, Too Late: Ineffective Regulation of Dietary Supplements in the United States
pmc.ncbi.nlm.nih.gov
Narrative Review: The FDA's Perfunctory Approach of Dietary Supplement Regulations Giving Rise to Copious Reports of Adverse Events - PubMed
PubMedOct 10, 2023
Re-Regulating Dietary Supplements
Saint Louis University Scholarship CommonsJan 1, 2023
FDA Inspection and Enforcement Authority for Food and Dietary Supplement Manufacturers
FDLI (Food and Drug Law Institute)Sep 1, 2024
GAO supplements report calls for tighter regulation - NutraIngredients-USA
NutraIngredients-USAMar 18, 2017
Reviewing the FDA's Regulatory Approach to Dietary Supplements | PharmExec
PharmExecDec 6, 2023

+ 7 more sources — see the full list on Lenz

Filed Under

AmphetamineAnabolic SteroidsDietary SupplementsThyroid HormoneUnited States Food and Drug Administration

Dietary supplements containing undisclosed pharmaceutical drugs — including steroids, thyroid hormones, and amphetamine-like stimulants — have been sold to consumers for years with limited regulatory consequence due to insufficient FDA enforcement capacity.

The Short Version

Caveats

The Receipts

Filed Under

More Fact Checks

Under the Dietary Supplement Health and Education Act of 1994, the U.S. Food and Drug Administration is prohibited from reviewing dietary supplements for safety or efficacy before they are marketed.

Collagen supplements in the United States are largely unregulated by the Food and Drug Administration due to the Dietary Supplement Health and Education Act of 1994.